Securities
May 20, 2010
Biotech IPOs Show Positive Signs
Biotechnology companies going public this year know that to make money they have to spend money on lawyers and financial advisors and the number of life science firms willing to make that investment is on an upswing.
Daily Journal Staff Writer
Biotech companies going public this year know that to make money they have to spend money on lawyers and financial advisors and the number of life science firms willing to make that investment is on an upswing.
After recording no initial public offerings in the biotech sector last year until August, 11 drug, medical device and biofuel companies have sold shares in the stock market si...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In